Literature DB >> 30327159

Targeted therapy use in adults with cancer ≥85 years of age.

Karen E Wickersham1, Molly Crothers2, Danielle Puth2, Miriam N Weiss2, Kendall Powell2, Barbara Resnick2.   

Abstract

PURPOSE: Assess patient- and clinical-related variables associated with targeted cancer treatments (TTs) for adults ≥85 years of age. RATIONALE: TTs have pathway-specific side effects that negatively affect QoL and medication adherence, which may reduce TT efficacy. Research has not focused on patients aged ≥85 years; therefore, the scope of TT use in this age group is not understood.
METHODS: We conducted an electronic medical record review to identify individuals ≥85 years treated with TT.
RESULTS: The sample (N = 295) was 53.5% male, 41% married/partnered, and 73.7% Caucasian. Common cancer types included breast (26.3%), prostate (31.3%), and leukemia (14.1%). Only one-third (n = 98) of the sample had TT side effects noted in their patient chart.
CONCLUSIONS: Patients aged ≥85 years took similar TTs and experienced similar side effects as reported by research of younger patients; however, symptom experience was not well-reported.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer survivorship; Geriatrics; Medication adherence; Symptoms

Mesh:

Substances:

Year:  2018        PMID: 30327159     DOI: 10.1016/j.gerinurse.2018.06.014

Source DB:  PubMed          Journal:  Geriatr Nurs        ISSN: 0197-4572            Impact factor:   2.361


  1 in total

1.  A Mentored Pathway into the Sciences for Underrepresented Populations: A Newly Crafted Educational Modality for Women Exploring Career Opportunities in Science, Technology, Engineering, Mathematics, and Medicine.

Authors:  Sheindel Ifrah Goldfeiz; Miriam Knoll; Reshma Jagsi; Chana Weinstock; James W Pennebaker; Linda Samuels; Daniel C Edelman
Journal:  Womens Health Rep (New Rochelle)       Date:  2020-09-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.